The post Hyperliquid Announces Support for ‘Outcomes’ Prediction Market Contracts appeared on BitcoinEthereumNews.com. Key Notes The HyperCore upgrade introducesThe post Hyperliquid Announces Support for ‘Outcomes’ Prediction Market Contracts appeared on BitcoinEthereumNews.com. Key Notes The HyperCore upgrade introduces

Hyperliquid Announces Support for ‘Outcomes’ Prediction Market Contracts

3 min read

Key Notes

  • The HyperCore upgrade introduces fully collateralized contracts settling within fixed ranges for prediction markets.
  • Testing phase precedes mainnet launch of canonical markets based on objective settlement sources.
  • HYPE token surged 8% on announcement, trading at $33.68 before stabilizing around $33.00.

Hyperliquid has announced an upgrade to the HyperCore engine which adds the new “HIP-4” protocol and support for “Outcomes” prediction market contracts.

Per a Feb. 2 post on twitter.com from the official Hyperliquid account, Outcomes are fully collateralized contracts that settle within a fixed range. These contracts can be used to support prediction markets, insurance-like products, and other bounded services.

The HIP-4 launch is being conducted as a test, according to Hyperliquid. “Outcomes are a work in progress and currently only being tested on testnet,” the team wrote, adding that “canonical markets based on objective settlement sources will be deployed once technical development is complete.”

Hyperliquid Expands Beyond Perpetuals

It’s unclear at this time how long the test will run for or when Hyperliquid plans to rollout Outcomes on mainnet. Upon full implementation, however, popular predictions market services such as Kalshi and Crypto.com could, ostensibly, leverage HIP-4 to operate on the HyperEVM blockchain.

The growing popularity of prediction markets combined with Hyperliquid’s explosive user growth in 2025, positions HyperEVM as an increasingly popular hub for high leverage traders seeking refuge activity through collateralized trading.

As Coinspeaker recently reported, prediction markets are now active in all 50 US states thanks to a strategic partnership between Kalshi and Coinbase. The sudden rise in popularity coincides with a friendlier regulatory environment with increased legal clarity in the US as well as a similar surges in interest for prediction markets in the EU and Asian sectors.

For its part, Hyperliquid saw its HYPE

HYPE
$32.01



24h volatility:
7.4%


Market cap:
$7.61 B



Vol. 24h:
$880.23 M

token rise more than 8% to $33.68 on the HIP-4 launch news before settling back to hover around $33.00. The flurry of activity puts HYPE up nearly 50% for the week and almost 35% for the month.

HYPE was up more than 8% after news broke, reaching a months-long high | Source: TradingView.

next

Disclaimer: Coinspeaker is committed to providing unbiased and transparent reporting. This article aims to deliver accurate and timely information but should not be taken as financial or investment advice. Since market conditions can change rapidly, we encourage you to verify information on your own and consult with a professional before making any decisions based on this content.

Cryptocurrency News, News


Tristan is a technology journalist and editorial leader with 8 years of experience covering science, deep tech, finance, politics, and business. Before joining Coinspeaker, he wrote for Cointelegraph and TNW.

Tristan Greene on X

Source: https://www.coinspeaker.com/hyperliquid-support-outcomes-prediction-market-contracts/

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.